Experienced Clinical Development professional
- Manager/Director, Clinical Development & Pharmacovigilance
Targovax is currently seeking an experienced Clinical Development professional who will be responsible for management of clinical studies and collaboration partners, as well as safety data. The new employee will be part of the Clinical Development team to support all aspects of clinical study operations and will also establish and manage a pharmacovigilance system for the company. Currently we have an open position as a Manager/Director, Clinical Development & Pharmacovigilance at our Oslo office.
As our new Manager/Director, Clinical Development & Pharmacovigilance, you will report to the Chief Medical Officer (CMO) and be responsible for the management of clinical studies in accordance with the Company’s business strategy and in compliance with GCP, and processing of safety data as of regulatory requirements. You will also monitor study performance, review and analyze data and follow-up Data Management systems and suppliers.
We are looking for you, with a university degree in a medical or scientific discipline alternatively a qualified health care professional, who have several years of experience of managing clinical research studies and pharmacovigilance processing where you worked according to international regulatory standards such as GCP and ICH. You also have experience with project management.
Other relevant qualifications are excellent written and oral communication skills in English, ability to work independently and at the same time be a good team player.
We can offer varied and exciting work in an innovative and an active biotech company. We promise you will develop professionally with challenging tasks in a growing company, as you participate in the development of novel cancer treatments. You will experience an informal and supportive company culture. Travelling abroad will be required from time to time.
Please send your CV and cover letter in English as soon as possible and no later than January 28th. For additional information please contact Renate Birkeli.
All applications will be treated confidentially.
Targovax is a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors. Targovax aims to unlock greater clinical benefits in cancer patients by deploying multifunctional platforms to target key immune regulators and oncogenic drivers. Targovax’s focus is to “activate the patient’s immune system to fight cancer”, thus extending and transforming the lives of cancer patients with targeted therapeutic cancer immunotherapies. The Group’s pipeline aims at different cancer indications, including melanoma, mesothelioma and colorectal cancer. The products are designed to harness the patient’s own immune system to fight the cancer, whilst also delivering a favorable safety and tolerability profile. Targovax has employees located both in Oslo, Norway and Espoo, Finland.
For more information about the company, please visit: www.targovax.com
- Vollsveien 19, 1366 Lysaker
- Farmasi og legemiddel,
- Forskning, utdanning og vitenskap,
- Helse og omsorg
- Helsepersonell / Farmasøyt,
Biotech, Kliniske studier
|Sist endret||25. feb. 2021 15:36|